Najlepsi lekarze wykonujący TK (tomografię komputerową) w Szanghaju – TOP 6 lekarzy

Dr Sun Guangxi jest gastroenterologiem w Szpitalu Tongji w Szanghaju. Wykonał tysiące bezbolesnych zabiegów gastroskopii i kolonoskopii. Specjalizuje się we wczesnym wykrywaniu i małoinwazyjnym leczeniu nowotworów układu pokarmowego. Dr Sun jest członkiem Towarzystwa Endoskopii Przewodu Pokarmowego Chińskiego Stowarzyszenia Medycznego.

• Specjalizuje się w bezbolesnej endoskopii z użyciem sedacji dożylnej w celu precyzyjnego wykrywania zmian.
• Wykonuje endoskopową dyssekcję podśluzówkową (ESD) oraz usuwanie złożonych polipów.
• Używa odręcznych rysunków, aby wyjaśnić pacjentom wyniki badań klinicznych.
• Leczy choroby żołądkowo-jelitowe, takie jak wrzodziejące zapalenie jelita grubego, choroba Leśniowskiego-Crohna i przełyk Barretta.

Dr Li Ping, M.D., Ph.D., jest głównym lekarzem i profesorem w Oddziale Hematologii Szpitala Shanghai Tongji, Szkoła Medyczna Uniwersytetu Tongji. Nadzoruje doktorantów i magistrantów oraz jest ekspertem w dziedzinie nowotworów hematologicznych.

Uzyskała stopień doktora nauk medycznych na Uniwersytecie w Nagoi i ukończyła badania podoktorskie. Specjalizuje się w diagnozowaniu i leczeniu nowotworów krwi. Jej zainteresowania obejmują nowotwory limfoidalne — białaczki, chłoniaki i szpiczaka mnogiego. Leczy pacjentów za pomocą chemioterapii, przeszczepiania krwiotwórczych komórek macierzystych, terapii celowanej i immunoterapii.

Jest pionierką w Chinach w zakresie pełnocyklowej terapii CAR-T w leczeniu nawrotowych lub opornych na leczenie nowotworów krwi. Kieruje krajowymi i międzynarodowymi badaniami klinicznymi oraz bierze w nich udział. Zasiada w komitetach towarzystw zawodowych, w tym w Chińskim Stowarzyszeniu Przeciwnowotworowym. Publikuje również prace naukowe i szkoli hematologów.

Dr. Wan Daqian, MD, PhD, is Associate Chief Physician and Master’s Supervisor in Orthopedics (Joint Surgery) at Shanghai Tongji Hospital. He focuses on joint surgery and sports medicine. He performs shoulder and knee arthroscopy and total hip and knee arthroplasty. He was among the first to use stem-cell therapy for osteoarticular bone-defect disease. His surgical volume ranks among the highest in the region.

He has led 7 grants, including one NSFC General Project. He has published over 20 SCI papers. Some sources report over 30 SCI papers among more than 40 articles, with 8 in Q1 journals, a cumulative impact factor over 100, and a maximum impact factor of 12.153. He has served as a guest editor for multiple journals. He co-authored one monograph.

Credentials and awards: He was mentored by Academician Dai Kerong. He was a visiting scholar in biomedical engineering at UC Berkeley. He received the Shanghai “Super Postdoctoral” award. He is a researcher with the Key Lab of Spine & Spinal Cord Injury (MOE). His honors include the Heilongjiang Medical & Health New Technology Award (Third Prize) and the Harbin Medical & Health New Technology Application Award (First Prize).

Dr. Ding Yi is the Associate Chief Physician in Hematology at Shanghai Tongji Hospital. She is also the acting deputy director of the Blood Transfusion Department. She holds a Master of Medicine from Tongji University. She serves on the Youth Committee of the Shanghai Society of Hematology.

She is skilled in diagnosing and treating leukemia, lymphoma, and myeloma. She offers hematopoietic and umbilical cord blood stem cell therapies. She specializes in acute leukemia. She developed sequential treatment protocols. She participated in research that won the Second Prize of the Shanghai Science and Technology Progress Award. She has published more than 10 papers.

Dr. Ma Bin, MD, PhD, is a Chief Physician and master's supervisor in Spinal Surgery at a tertiary hospital. He has more than 20 years of experience. His work focuses on degenerative spine disease and minimally invasive surgery. He is skilled in PELD, percutaneous pedicle screw fixation, and tubular retractor-assisted decompression and fusion.

He serves on the Minimally Invasive Spine Surgery Committee of the Chinese Orthopaedic Association. He is also a standing committee member of the Spine Minimally Invasive Professional Committee of the Chinese Medical Doctor Association. He is a frequent keynote speaker at national conferences. He has led or joined several provincial and ministerial projects. He has published more than 20 papers in core domestic and SCI-indexed journals. His findings are widely cited, and some have been adopted into clinical guidelines.

Dr. Shen Yuqin, MD, PhD, is Professor and Chief Physician at Shanghai Tongji Hospital. Dr. Shen directs the Rehabilitation Medicine Center and the Cardiac Rehabilitation Department. A doctoral supervisor and National Advanced Worker, Dr. Shen is a pioneer in cardiac rehabilitation for heart failure.

Dr. Shen was the first in China to implement cardiopulmonary exercise testing (CPET)-guided rehabilitation for heart failure. Dr. Shen also introduced the use of the anaerobic threshold to prescribe exercise intensity. The team created a nationwide hospital–community–home closed-loop model. In 2020, they opened Shanghai’s only inpatient cardiac rehabilitation ward in a tertiary hospital.

Dr. Shen is the principal investigator of two NSFC General Projects. Honors include the CRMA Science and Technology Award, First Prize (2019), and the Shanghai Rehabilitation Medicine Science and Technology Progress Awards, First Prize (2018, 2024). Dr. Shen has published over 50 papers as first or corresponding author. Dr. Shen served as chief editor of one monograph and associate editor of two. The portfolio includes 22 patents (15 authorized, including three invention patents) and five software copyrights. Nine technology transfers have been completed.

Dr. Shen is a Fellow of the American Association of Cardiovascular and Pulmonary Rehabilitation (FAACVPR) and a CDQI certified expert. Dr. Shen serves as an associate editor and editorial board member. Dr. Shen led the drafting of eight consensuses, guidelines, and standards, and organized 20 national courses. The center has served more than 10,000 patients. The care model has been extended across Shanghai and introduced in Yunnan.